Technical Analysis for AUPH - Aurinia Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade B 15.44 2.93% 0.44
AUPH closed up 2.93 percent on Friday, December 6, 2019, on 4.95 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical AUPH trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Slingshot Bullish Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%

Older signals for AUPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development of a therapeutic drug to treat autoimmune diseases in Canada. The company's lead drug includes Voclosporin, a calcineurin inhibitor for the treatment of lupus nephritis. It has a development and license agreement with 3SBio Inc. for the clinical development, registration, and commercialization of voclosporin in China; and licensing and collaboration agreement with Vifor Pharma for the treatment of lupus and various proteinuric nephrology indications. The company was formerly known as Isotechnika Pharma Inc. and changed its name to Aurinia Pharmaceuticals Inc. in October 2013. Aurinia Pharmaceuticals Inc. was founded in 1993 and is headquartered in Victoria, Canada.
Medicine Biopharmaceutical Life Sciences Drugs Autoimmune Diseases Immunosuppressants Peptides Lupus Lupus Nephritis Treatment Of Lupus

Is AUPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.48
52 Week Low 3.52
Average Volume 2,824,409
200-Day Moving Average 6.16
50-Day Moving Average 5.82
20-Day Moving Average 7.21
10-Day Moving Average 8.90
Average True Range 1.15
ADX 46.67
+DI 66.71
-DI 5.82
Chandelier Exit (Long, 3 ATRs ) 14.02
Chandelier Exit (Short, 3 ATRs ) 8.36
Upper Bollinger Band 12.93
Lower Bollinger Band 1.48
Percent B (%b) 1.22
BandWidth 159.05
MACD Line 1.80
MACD Signal Line 0.89
MACD Histogram 0.9094
Fundamentals Value
Market Cap 1.29 Billion
Num Shares 83.5 Million
EPS -1.30
Price-to-Earnings (P/E) Ratio -11.88
Price-to-Sales 1112.47
Price-to-Book 2.62
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.16
Resistance 3 (R3) 18.06 17.07 17.70
Resistance 2 (R2) 17.07 16.38 17.11 17.55
Resistance 1 (R1) 16.25 15.95 16.66 16.35 17.40
Pivot Point 15.26 15.26 15.46 15.30 15.26
Support 1 (S1) 14.44 14.57 14.85 14.54 13.48
Support 2 (S2) 13.45 14.14 13.49 13.33
Support 3 (S3) 12.63 13.45 13.18
Support 4 (S4) 12.73